Lehmberg Jens, Beck Jürgen, Baethmann Alexander, Uhl Eberhard
Department of Neurosurgery, Breisacher Str. 64, 79106 Freiburg, Germany.
J Neurol. 2006 Mar;253(3):357-63. doi: 10.1007/s00415-005-0996-4. Epub 2005 Oct 10.
Cerebral ischemia induces activation of leukocyte-endothelium interactions requiring upregulation of specific adhesion molecules including the selectins. The aim of the current study was to elucidate the therapeutic potency of P-selectin blockade on microcirculatory disturbances and secondary brain damage after global cerebral ischemia. Global cerebral ischemia for 15 minutes was induced in Mongolian gerbils. Functional blockade of P-selectin was achieved by pretreatment with the antibody RB 40.34 (2 mg/kg, n = 7). In vivo observation of brain microcirculation was performed by epifluorescence microscopy of a cranial window. Survival was assessed daily up to 4 days after ischemia. In the control group leukocyte rolling increased during reperfusion with a maximum at 3 h (28 +/- 14 x 100 microm(-1) x min(-1)) and was significantly reduced by the P-selectin antibody (13 +/- 9 x 100 microm(-1) x min(-1), p < 0.05). No effect on firm leukocyte adhesion was observed (4 +/- 3 vs. 2 +/- 1 x 100 microm(-1) x min(-1)). The survival of animals that received the Pselectin antibody (28 %) was significantly reduced compared with controls (71 %). Anti-P-selectin antibody reduces leukocyte rolling but has no positive effect on survival. Our data question the role of the inflammatory response in the development of secondary brain damage and do not support this kind of therapeutical approach in global cerebral ischemia.
脑缺血会诱导白细胞与内皮细胞相互作用的激活,这需要上调包括选择素在内的特定黏附分子。本研究的目的是阐明P-选择素阻断对全脑缺血后微循环紊乱和继发性脑损伤的治疗效果。在蒙古沙鼠中诱导15分钟的全脑缺血。通过用抗体RB 40.34(2mg/kg,n = 7)预处理实现P-选择素的功能阻断。通过颅窗落射荧光显微镜对脑微循环进行体内观察。在缺血后长达4天每天评估存活率。在对照组中,白细胞滚动在再灌注期间增加,在3小时时达到最大值(28±14×100μm-1×min-1),并且被P-选择素抗体显著降低(13±9×100μm-1×min-1,p <0.05)。未观察到对牢固白细胞黏附的影响(4±3对2±1×100μm-1×min-1)。接受P-选择素抗体的动物的存活率(28%)与对照组(71%)相比显著降低。抗P-选择素抗体减少白细胞滚动,但对存活率没有积极影响。我们的数据质疑炎症反应在继发性脑损伤发展中的作用,并且不支持在全脑缺血中采用这种治疗方法。